Clinical Trials Browser

GC1118 × Clear all

NCT03618667 2023-05-12

GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification

Phase 2 Completed

Glioblastoma

NCT04077255 2022-11-30

EGFR-targeted Therapy for Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma of the Stomach

NCT02352571 2016-07-06

Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer

Phase 1 Unknown

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms